CBX-663

N/A

Report date: 2025/07/30 16:13:06

Base Information

Drug NameCBX-663
Drug Alias NameCBX-663
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > TCR therapy
Mechanisms of ActionTelomerase reverse transcriptase modulators
TargetsTelomerase reverse transcriptase
Therapy Area/IndicationsSolid tumoursHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossbow Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrossbow Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A